IL27信号作为固有细胞毒性细胞的免疫检查点促进肝细胞癌
研究发现IL27受体(IL27R)信号在体内促进肝细胞癌(HCC)发展,高IL27EBI3或IL27RA表达与HCC患者不良预后相关。在两种肝癌发生模型中,IL27R缺失抑制HCC;机制上IL27R信号在肿瘤微环境中限制固有细胞毒性淋巴细胞的细胞毒性。药理学中和IL27信号可增加固有细胞毒性淋巴细胞浸润并减少HCC发展,提示IL27通路阻断在HCC中具有治疗潜力。
要点
- 高IL27EBI3或IL27RA表达与HCC患者不良预后相关。
- IL27R缺失在两种肝癌发生模型中抑制HCC。
- 药理学中和IL27信号减少HCC发展并增强固有细胞毒性淋巴细胞浸润。
核心结论
- IL27R信号作为免疫检查点调控固有细胞毒性淋巴细胞并促进不同病因的HCC,提示IL27通路阻断在HCC中具有治疗潜力。
研究设计与样本
- 研究采用体内HCC模型和患者样本分析,探讨IL27R信号在HCC中的作用。
主要发现
- 高IL27EBI3细胞因子或IL27RA表达与HCC患者不良预后相关。
- 在两种肝癌发生模型中,IL27R缺失抑制体内HCC。
- IL27R信号在肿瘤微环境中限制固有细胞毒性淋巴细胞的细胞毒性。
- IL27R缺失增强固有细胞毒性淋巴细胞的积累和活化,而清除或功能损伤固有细胞毒性细胞则消除IL27R缺失的效果。
- 药理学中和IL27信号增加固有细胞毒性淋巴细胞浸润并上调细胞毒性分子,减少HCC发展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Although inflammatory mechanisms driving hepatocellular carcinoma (HCC) have been proposed, the regulators of anticancer immunity in HCC remain poorly understood. We found that IL27 receptor (IL27R) signaling promotes HCC development in vivo. High IL27EBI3 cytokine or IL27RA expression correlated with poor prognosis for patients with HCC. Loss of IL27R suppressed HCC in vivo in two different models of hepatocarcinogenesis. Mechanistically, IL27R sig-naling within the tumor microenvironment restrains the cytotoxicity of innate cytotoxic lymphocytes. IL27R ablation enhanced their accumulation and activation, whereas depletion or functional impairment of innate cytotoxic cells abrogated the effect of IL27R disruption. Pharmacologic neutralization of IL27 signaling increased infiltration of innate cytotoxic lymphocytes with upregulated cytotoxic molecules and reduced HCC development. Our data reveal an unexpected role of IL27R signaling as an immunologic checkpoint regulating innate cytotoxic lymphocytes and promoting HCC of different etiologies, thus indicating a therapeutic potential for IL27 pathway blockade in HCC. SIGNIFICANCE: HCC, the most common form of liver cancer, is characterized by a poor survival rate and limited treatment options. The discovery of a novel IL27-dependent mechanism controlling anticancer cytotoxic immune response will pave the road for new treatment options for this devastating disease. This article is highlighted in the In This Issue feature, p. 1825.
引用
- Aghayev T, Mazitova AM, Fang JR, et al. IL27 Signaling Serves as an Immunologic Checkpoint for Innate Cytotoxic Cells to Promote Hepatocellular Carcinoma. Cancer Discov. 2022. PMID: 35723626. doi:10.1158/2159-8290.CD-20-1628
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。